Ch. 13 Principles Of Pharmacology Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

Absolute refractory period

A

The early phase of cardiac depolarization, wherein the heart muscle cannot be stimulated to depolarize; also known as the effective refractory period.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Absorption

A

The process by which the molecules of a substance are moved from the site of entry or administration into systemic circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Acetylcholinesterase

A

An enzyme that breaks down acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Active metabolite

A

A medication that has undergone bio transformation and is able to alter a cellular process or body function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

active transport

A

The process of molecules binding with carrier proteins when energy is used to move molecules against a concentration gradient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Adverse effect

A

Abnormal or harmful effect to an organism caused by exposure to a chemical. It is indicated by some result such as death, a change in food or water consumption, altered body and organ weights, altered enzyme levels, or visible illness.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Affinity

A

The ability of a medication to bind with a particular receptor site.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Agonist medications

A

The group of medications that initiates or alters a cellular activity by attaching to receptor sites, prompting a cellular response.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Analgesia

A

The state of being insensible to pain while still conscious

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Anaphylaxis

A

An extreme systemic form of an allergic reaction involving two or more body systems

A form of shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Anesthetic

A

A medication that causes the inability to feel sensation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Antagonist medication

A

The group of medications that prevent endogenous or exogenous agonist chemicals from reaching cell receptor sites and initiating or altering a particular cellular activity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Antibiotics

A

The medications used to fight infection by killing the microorganisms or preventing their multiplication to allow the body’s immune system to overcome them.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Anti fun gals

A

The medications used to treat fungal infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Antimicrobials

A

The medications used to kill or suppress the growth of microorganisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Automaticity

A

A state in which cardiac cells are at rest, waiting for the generation of a spontaneous impulse from within

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Bioavailability

A

The percentage of the unchanged medication that reaches systemic circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Bio transformation

A

A process with four possible effects on a medication absorbed into the body.
1- an inactive substance can become active, capable of producing desired or unwanted clinical effects
2- an active medication can be changed into another active medication.
3- an active medication may be completely or partially inactivated.
4- a medication is transformed into a substance ( active or inactive) that is easier for the body to eliminate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Bronchoconstriction

A

Narrowing of the bronchial tubes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Bronchodilation

A

Widening of the bronchial tubes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Chelating agents

A

Medications that bind with heavy metals in the body and create a compound that can be eliminated; used in cases of ingestion or poisoning

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Cholinergic

A

A term used to describe the fibers in the parasympathetic nervous system that releases a chemical called acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Class

A

The grouping to which a education belongs.

Medications are grouped according to their characteristics, traits, or primary components

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Competitive agonists

A

Medications that temporarily bind with cellular receptor sites, displacing agonist chemicals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Competitive depolarizing

A

A term used to describe paralytic agents that act at the neuromuscular junction by binding with nicotinic receptors on muscles, causing fasciculations and preventing additional activation by acetylcholine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Contraindications

A

Any condition, especially Any condition of disease, that renders some particular line of treatment improper or undesirable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Cross tolerance

A

A process in which repeated exposure to a medication within a particular class causes tolerance that may be “transferred” to other medications in the same class

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Cumulative action

A

Several smaller doses of a particular medication capable of producing the same clinical effects as a single layer dose of that same medication

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Cytochrome P-450 system

A

A hemoprotein involved in the detoxification of many drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Dependence

A

The physical, behavioral, or emotional need for a medication or chemical to maintain “normal” physiologic functions.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Depolarization

A

The process of discharging resting cardiac muscle fibers by an electric impulse that causes them to contract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Depressant

A

A chemical or medication that decreases the performance of the central nervous system or sympathetic nervous system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Digitalis preparation

A

A drug used in the treatment of heart failure and certain atrial dysrhythmias

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

Distribution

A

The movement and transportation of a medication throughout the bloodstream to tissues and cells and, ultimately, to its target receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

Diuretic

A

A chemical that increases urinary output

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

Dose-response curve

A

A graphic illustration of the response of a drug according to the dose administered

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

Dosing

A

The specified amount of a medication to be given at specific intervals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

Down-regulation

A

The process in which a mechanism reducing available cell receptors for a particular medication results in tolerance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Drug

A

A substance that has some therapeutic effect (such as reducing inflammation, fighting bacteria, or producing euphoria) when given in the appropriate circumstances and in the appropriate dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Duration (of action)

A

In a pharmacological context, the time a medication concentration can be expected to remain above the minimum level needed to provide the intended action

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Dystonic

A

Pertaining to voluntary muscle movements that are distorted or impaired because of abnormal muscle tone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Ectopic foci

A

Sites of generation of electrical impulses other than normal pacemaker cells.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

Efficacy

A

In a pharmacologic context, the ability of a medication to produce the desired effect.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

Elimination

A

In a pharmacologic context, the removal of a medication or its by products from the body.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

Endogenous

A

Originating from within the organism (body).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Exogenous

A

Originating outside the organism (body)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Extravasation

A

Seepage of blood and medication into the tissue surrounding the blood vessel.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Facilitated diffusion

A

The process of medication molecules binding with carrier proteins when no energy is expended

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Fasciculation

A

Brief, uncoordinated, visible twitching of small muscle groups; may be caused by the administration of a depolarizing neuromuscular blocking agent (namely, succinylcholine)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Filtration

A

Use of hydrostatic pressure to force water or dissolved particles through a semipermeable membrane

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

First order elimination

A

The process in which the rate of elimination is directly influenced by plasma levels of a substance.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

First pass effect

A

The alteration of a medication via metabolism within the gastrointestinal tract before it reaches systemic circulation

53
Q

Habituation

A

The unusual tolerance to the therapeutic and adverse clinical effects of a medication or chemical

54
Q

Half life

A

The time needed in an average person for metabolism or elimination of 50% of a substance in the plasma

55
Q

Hematocrit

A

The percentage of red blood cells in a blood sample.

56
Q

Hemolysis

A

The destruction of red blood cells by disruption of the cell membrane.

57
Q

Hydrophilic

A

Attached to water molecules.

58
Q

Idiosyncratic

A

In a pharmacologic context, abnormal susceptibility to a medication, possibly due to genetic traits or dysfunction of a metabolic enzyme, that is peculiar to an individual patient (and usually unexplained)

59
Q

Inactive metabolite

A

A medication that has undergone biotransformation and is no longer able to alter a cell process or body function; not pharmacologically active.

60
Q

Indication

A

A circumstance that points to or shows the cause, pathology, treatment, or issue of an attractive of disease; that which points out; that which serves as a guide or warning.

61
Q

Interference

A

One medication or chemical taken by a patient that undermines the effectiveness of another medication taken by or administered to a patient.

62
Q

Lipophilic

A

Attracted to fats and lipids

63
Q

Mechanism of action

A

The way in which a medication produced the intended response.

64
Q

Median effective dose (ED50)

A

The weight-based dose of a medication that was effective in 50% of humans and animals tested.

65
Q

Median lethal dose (LD50)

A

The weight based dose of medication that caused death in 50% of the animals tested.

66
Q

Median toxic dose (TD50)

A

The weight based dose of a medication that demonstrated toxicity in 50% of the animals tested.

67
Q

Medication

A

A substance used to treat an illness or condition

68
Q

Medication monograph

A

A document that gives detailed information about drugs, such as the indications and uses, dosing information, precautions, contraindications, and adverse effects.

69
Q

Medication sensitivity

A

A mild to severe reaction after the first exposure to a medication or other substance, often with may of the same signs and symptoms as an immune-mediated reaction.

70
Q

Noncompetitive antagonists

A

Medications that permanently bind with receptor sites and prevent activation by agonists chemicals.

71
Q

Nondepolarizing

A

A term used to descrbe drugs that produce muscle relaxation by interfering with impulses between the nerve ending and muscle receptor

72
Q

Nonionic

A

Uncharged

73
Q

Onset

A

The time needed for the concentration of the medication at the target tissue to reach the minimum effective level

74
Q

Orthostatic hypotension

A

A fall in blood pressure when changing to a standing position

75
Q

Osmosis

A

The movement of a solvent, such as water, from an area of low solute concentration to one of high concentration through a selectively permeable membrane to equalize concentrations of a solute on both sides of the membrane.

76
Q

Osmotic

A

Characterized by the movement of a solvent, such as water, across a semipermeable membrane from an area of lower solute concentration to one of higher concentration.

77
Q

Paradoxical

A

Opposite from expected

78
Q

Partial agonist

A

A chemical that binds to the receptor site but does not initiate as much cellular activity or change as other agonists do; lowers the efficacy of other agonist chemicals present at the cells.

79
Q

Peak

A

In a pharmacologic context, the point of maximum effect of a drug.

80
Q

Pharmacodynamics

A

The biochemical and physiologic effects and mechanism of action of a medication in the body.

81
Q

Pharmacokinetics

A

The activity of medications in the body over time, such as absorption, distribution, and elimination.

82
Q

Pharmacology

A

The scientific study of how various substances interact with or alter the function of living organisms.

83
Q

Pinocytosis

A

A process by which cells ingest the extracellular fluid and its contents.

84
Q

Placebo effect

A

In a pharmacologic context, the positive and negative effects on an inactive medication on a person that are related to the person’s expectations and other factors.

85
Q

Plasma protein binding

A

A process in which medication molecules temporarily attach to proteins in the blood plasma, significantly altering medication distributing in the body.

86
Q

Potency

A

The relationship between the desired response of a medication and the dose required to achieve the response.

87
Q

Receptor

A

A specialized area in tissues that initiates certain actions after specific stimulation.

88
Q

Relative refractory period

A

The period in the cell firing cycle at which it is possible but difficult to restimulate the cell to fire another impulse

89
Q

Stevens-Johnson syndrome

A

A severe, possibly fatal reaction that mimics a burn; may be due to a medication

90
Q

Stimulant

A

A medication or chemical that temporarily enhances central nervous system and sympathetic nervous system functioning.

91
Q

Sympathomimetics

A

Medications administered to stimulate the sympathetic nervous system.

92
Q

Tachyphylaxis

A

A condition in which repeated doses of medication within a short period rapidly cause tolerance, making the medication virtually ineffective.

93
Q

Therapeutic index

A

The relationship between the median effective dose and the median lethal dose or median toxic dose; also known as the therapeutic ratio.

94
Q

Threshold level

A

In pharmacologic context, the concentration of medication at which initiation or alteration of cellular activity begins.

95
Q

Tolerance

A

A condition that develops following repeated use by a patient of a medication that results in decreased efficacy or potency.

96
Q

Untoward effect

A

A clinical change caused by a medication that causes harm or discomfort to a patient; also known as adverse effect

97
Q

Vasoconstriction

A

Narrowing of the diameter of a blood vessel

98
Q

Vasodilation

A

Widening of the diameter of a blood vessel.

99
Q

Vaughan-Williams classification

A

A classification scheme based on the mechanism of action rather than on specific medication groups

100
Q

Volume of distribution

A

The extent to which a medication will spread within the body.

101
Q

Water-soluble

A

A property that indicates a material can be dissolved in water.

102
Q

Zero-order elimination

A

A process in which a fixed amount of a substance is removed during a certain period, regardless of the total amount in the body.

103
Q

Microorganisms such as bacteria, fungi, and mold are used for….

A

To manufacture medication

104
Q

Schedule of drugs from the FDA

A

Classifies meds with potential abuse into five categories.

1- high abuse potential (no recognized med purpose): heroin, marijuana, LSD

2- High abuse potential (legitimate med purpose): fentanyl, methylphenidate (Ritalin), cocaine

3- Lower potential for abuse than schedule 2: Vicodin, acetaminophen with codeine (Tylenol with codeine #3), ketamine

4- Lower potential for abuse than schedule 3: Diazepam (valium), lorazepam (Ativan)

5- lower potential for abuse than schedule 4: narcotic cough medicine.

105
Q

Synthetic

A

Made completely in a laboratory setting

106
Q

Semisynthetic

A

Made from chemicals derived from plant, animal, or mineral sources that have been chemically modified in the laboratory setting)

107
Q

Benzodiazepine medications have what stem?

A

Am

Example: midazolam, diazepam, lorazepam

108
Q

Angiotensin converting enzyme (ACE) inhibitor medications have what stem?

A

Pril

Example: enalapril (vasotec), captopril (Capoten), lisinopril (prinivil, zestril)

109
Q

AHA classification for use of medication for a certain condition

A
Class 1
Class 2a
Class 2b
Class 3
Class indeterminate
110
Q

Class 1

A

Indicates there is strong evidence supporting the use of the medication for the condition

111
Q

Class 2a

A

Indicates moderate evidence

112
Q

Class 2b

A

Indicates weak evidence

113
Q

Class 3

A

Indicates the evidence does not support that there is a benefit and may support that there is a harmful consequence; the treatment is not helpful and may be harmful

114
Q

Class indeterminate

A

Indicates either that research is beginning on a treatment or that research is continuing on a treatment. There are no recommendations until further research is performed

115
Q

Receptor sites within the body

A
Alpha 1
Alpha 2
Beta 1
Beta 2
Dopaminergic
Nicotinic
Muscarinic 2
Opioid
116
Q

Alpha 1

A

Vasoconstriction of arteries and veins

117
Q

Alpha 2

A

Insulin restriction
Glucagon secretion
Inhibition of norepinephrine release

118
Q

Beta 1

A

Increases heart rate (chronotropic effect)
Increases myocardial contractility (inotropic effect)
Increased myocardial conduction (dromotropic effect)
Renin secretion for urinary retention

119
Q

Beta 2

A

Bronchus and bronchiole relaxation
Insulin secretion
Uterine relaxation
Arterial dilation in certain key organs

120
Q

Dopaminergic receptor site

A

Vasodilation of renal and mesenteric arteries

121
Q

Nicotinic receptor site

A

Present at neuromuscular junction, allowing ACh to stimulate muscle contraction

122
Q

Muscarinic 2

A

Present in the heart; activated by ACh to offset stimulation of the sympathetic nervous system, decreasing heart rate, contractility, and electrical conduction velocity.

123
Q

Bicarbonate ions are able to bind with excess hydrogen ions doing what?

A

Raising the pH and decreasing the acidity of various body fluids.

124
Q

Medications distribute into three primary types of body substances following administration. What are they?

A

Water, fat, and protein

125
Q

What meds are generally viewed as ineffective and are not indicated for hypothermic cardiac arrest?

A

Atropine sulfate and lidocaine

126
Q

Teratigen

A

Abnormalities during pregnancy to the baby

127
Q

Fastest route

A

IV

128
Q

Slowest route

A

Topical

129
Q

pharmacokinetics section of medication profiles typically refers to the …

A

Onset
Peak
Duration of effect